128 related items for PubMed ID: 18328154
1. In etanercept-treated psoriatic arthritis patients clinical improvement correlated with an increase of serum cortisol relative to other adrenal hormones.
Atzeni F, Sarzi-Puttini P, DePortu S, Cutolo M, Carrabba M, Straub RH.
Clin Exp Rheumatol; 2008; 26(1):103-8. PubMed ID: 18328154
[Abstract] [Full Text] [Related]
2. Psoriatic arthritis: clinical improvement and correlation with hormone axes in etanercept-treated patients.
Atzeni F, Straub RH, Cutolo M, Sarzi-Puttini P.
Ann N Y Acad Sci; 2010 Apr; 1193():176-8. PubMed ID: 20398026
[Abstract] [Full Text] [Related]
3. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
Straub RH, Pongratz G, Schölmerich J, Kees F, Schaible TF, Antoni C, Kalden JR, Lorenz HM.
Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
[Abstract] [Full Text] [Related]
4. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
Straub RH, Härle P, Yamana S, Matsuda T, Takasugi K, Kishimoto T, Nishimoto N.
Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
[Abstract] [Full Text] [Related]
5. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.
Straub RH, Pongratz G, Cutolo M, Wijbrandts CA, Baeten D, Fleck M, Atzeni F, Grunke M, Kalden JR, Schölmerich J, Lorenz HM, Tak PP, Sarzi-Puttini P.
Arthritis Rheum; 2008 Apr; 58(4):976-84. PubMed ID: 18383357
[Abstract] [Full Text] [Related]
6. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
Ernestam S, Hafström I, Werner S, Carlström K, Tengstrand B.
J Rheumatol; 2007 Jul; 34(7):1451-8. PubMed ID: 17477470
[Abstract] [Full Text] [Related]
7. Infusion of epinephrine decreases serum levels of cortisol and 17-hydroxyprogesterone in patients with rheumatoid arthritis.
Straub RH, Kittner JM, Heijnen C, Schedlowski M, Schmidt RE, Jacobs R.
J Rheumatol; 2002 Aug; 29(8):1659-64. PubMed ID: 12180725
[Abstract] [Full Text] [Related]
8. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
Härle P, Straub RH, Wiest R, Mayer A, Schölmerich J, Atzeni F, Carrabba M, Cutolo M, Sarzi-Puttini P.
Ann Rheum Dis; 2006 Jan; 65(1):51-6. PubMed ID: 15941834
[Abstract] [Full Text] [Related]
9. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
Cutolo M, Straub RH, Foppiani L, Prete C, Pulsatelli L, Sulli A, Boiardi L, Macchioni P, Giusti M, Pizzorni C, Seriolo B, Salvarani C.
J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
[Abstract] [Full Text] [Related]
10. Activity of the neuroendocrine axes in patients with polymyalgia rheumatica before and after TNF-α blocking etanercept treatment.
Kreiner FF, Galbo H.
Arthritis Res Ther; 2012 Aug 15; 14(4):R186. PubMed ID: 22894827
[Abstract] [Full Text] [Related]
11. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
Straub RH, Paimela L, Peltomaa R, Schölmerich J, Leirisalo-Repo M.
Arthritis Rheum; 2002 Mar 15; 46(3):654-62. PubMed ID: 11920401
[Abstract] [Full Text] [Related]
12. Soluble biomarkers associated with response to treatment with tumor necrosis factor inhibitors in psoriatic arthritis.
Chandran V, Shen H, Pollock RA, Pellett FJ, Carty A, Cook RJ, Gladman DD.
J Rheumatol; 2013 Jun 15; 40(6):866-71. PubMed ID: 23637322
[Abstract] [Full Text] [Related]
13. Improvement of ACTH response to insulin tolerance test in female patients with rheumatoid arthritis due to tumor necrosis factor inhibition.
Daza L, Martin-Jimenez R, De la Torre PX, Hernández E, Murillo B.
Eur J Endocrinol; 2007 Jul 15; 157(1):47-51. PubMed ID: 17609401
[Abstract] [Full Text] [Related]
14. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B, Teller C, Yamauchi P, Miller JL, Hooper M, Yang YC, Dann F.
Br J Dermatol; 2008 Aug 15; 159(2):322-30. PubMed ID: 18503600
[Abstract] [Full Text] [Related]
15. Adrenocortical response to low-dose ACTH test in female patients with rheumatoid arthritis.
Radikova Z, Rovensky J, Vlcek M, Penesova A, Kerlik J, Vigas M, Imrich R.
Ann N Y Acad Sci; 2008 Dec 15; 1148():562-6. PubMed ID: 19120158
[Abstract] [Full Text] [Related]
16. Sustained clinical response in psoriatic arthritis patients treated with anti-TNF agents: a 5-year open-label observational cohort study.
Saougou I, Markatseli TE, Papagoras C, Voulgari PV, Alamanos Y, Drosos AA.
Semin Arthritis Rheum; 2011 Apr 15; 40(5):398-406. PubMed ID: 20843542
[Abstract] [Full Text] [Related]
17. The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis.
Anandarajah AP, Schwarz EM, Totterman S, Monu J, Feng CY, Shao T, Haas-Smith SA, Ritchlin CT.
Ann Rheum Dis; 2008 Mar 15; 67(3):296-301. PubMed ID: 17967829
[Abstract] [Full Text] [Related]
18. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
Vogl D, Falk W, Dorner M, Schölmerich J, Straub RH.
J Rheumatol; 2003 Feb 15; 30(2):269-75. PubMed ID: 12563679
[Abstract] [Full Text] [Related]
19. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
J Clin Endocrinol Metab; 1988 Jul 15; 67(1):154-60. PubMed ID: 2837498
[Abstract] [Full Text] [Related]
20. Determination of lymphotoxin-alpha levels in patients with psoriatic arthritis undergoing etanercept treatment.
Murdaca G, Colombo BM, Contini P, Puppo F.
J Interferon Cytokine Res; 2012 Jun 15; 32(6):277-9. PubMed ID: 22480318
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
